PURDUE PHARMA LP logo

PURDUE PHARMA LP

282 Marks
LP
First Filed:Jun 14, 1932Latest Filed:Mar 18, 2026Address:201 Tresser Boulevard, 9th Floor, Stamford, CT 06901, US

Portfolio Overview

Registered
17(6%)
Pending
8(3%)
Dead
257(91%)
Previous
4

Top Classes

Class 5
Pharmaceuticals
224(79%)
Class 16
Paper Goods and Printed Matter
21(7%)
Class 44
Medical, beauty and agricultural services
15(5%)

TTAB Proceedings

Total Proceedings
30
As Plaintiff
23(77%)
As Defendant
7(23%)

Top Firms

Loading...

Trademark Activity Timeline(1982 – 2026)

Trademark Portfolio

286 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
NALMEFENE HCL
NALMEFENE HCL
Trademark
Combined
PENDING
Owner:
Serial:99710822
Filed:Mar 18, 2026
Classes:5
99402638
99402638
Trademark
Design
PENDING
Owner:
Serial:99402638
Filed:Sep 19, 2025
Classes:5
Goods & Services
Class 005: Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
ZURNAI
ZURNAI
Trademark
Word
PENDING
Owner:
Serial:98597572
Filed:Jun 12, 2024
Classes:5
Goods & Services
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
97306624
97306624
Trademark
Design
ABANDONED
Owner:
Serial:97306624
Filed:Mar 10, 2022
Classes:5
Goods & Services
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
NALMEFENE HCL
NALMEFENE HCL
Trademark
Combined
PENDING
Owner:
Serial:97306650
Filed:Mar 10, 2022
Classes:5
Goods & Services
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists; "NALMEFENE HCL"
K
K
Trademark
Combined
PENDING
Owner:
Serial:97132237
Filed:Nov 18, 2021
Classes:5, 42
Goods & Services
A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists; Pharmaceutical research and development
K KNOA PHARMA
K KNOA PHARMA
Trademark
Stylized
PENDING
Owner:
Serial:97132159
Filed:Nov 18, 2021
Classes:5, 42
Goods & Services
A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists; "PHARMA"; Pharmaceutical research and development
KNOA PHARMA
KNOA PHARMA
Trademark
Word
PENDING
Owner:
Serial:97009389
Filed:Sep 2, 2021
Classes:5, 42
Goods & Services
A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists; "PHARMA"; Pharmaceutical research and development
KNOA PHARMACEUTICALS
KNOA PHARMACEUTICALS
Trademark
Word
PENDING
Owner:
Serial:97009404
Filed:Sep 2, 2021
Classes:5, 42
Goods & Services
A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists; "PHARMACEUTICALS"; Pharmaceutical research and development
NAMFERO
NAMFERO
Trademark
Word
ABANDONED
Owner:
Serial:90518812
Filed:Feb 8, 2021
Classes:5
Goods & Services
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
NYLREVA
NYLREVA
Trademark
Word
ABANDONED
Owner:
Serial:90518463
Filed:Feb 8, 2021
Classes:5
Goods & Services
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
NYMCERO
NYMCERO
Trademark
Word
ABANDONED
Owner:
Serial:90518513
Filed:Feb 8, 2021
Classes:5
Goods & Services
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
ZALLQU
ZALLQU
Trademark
Word
ABANDONED
Owner:
Serial:90518556
Filed:Feb 8, 2021
Classes:5
Goods & Services
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
IMBRIUM THERAPEUTICS
IMBRIUM THERAPEUTICS
Trademark
Combined
ABANDONED
Owner:
Serial:88474363
Filed:Jun 14, 2019
Classes:5
Goods & Services
"THERAPEUTICS"
IMBRIUM THERAPEUTICS
IMBRIUM THERAPEUTICS
Trademark
Combined
ABANDONED
Owner:
Serial:88474325
Filed:Jun 14, 2019
Classes:5
Goods & Services
"THERAPEUTICS"
IMBRIUM THERAPEUTICS
IMBRIUM THERAPEUTICS
Trademark
Combined
REGISTERED
Owner:
Serial:88977525
Filed:Jun 14, 2019
Classes:5
Registration:6076746
Registered:Jun 9, 2020
Goods & Services
Pharmaceutical preparations for the treatment of central nervous system disorders; "THERAPEUTICS"
IMBRIUM THERAPEUTICS
IMBRIUM THERAPEUTICS
Trademark
Combined
REGISTERED
Owner:
Serial:88977524
Filed:Jun 14, 2019
Classes:5
Registration:6076745
Registered:Jun 9, 2020
Goods & Services
Pharmaceutical preparations for the treatment of central nervous system disorders; "THERAPEUTICS"
IMBRIUM LIFESCIENCES
IMBRIUM LIFESCIENCES
Trademark
Word
ABANDONED
Owner:
Serial:88094449
Filed:Aug 27, 2018
Classes:5
Goods & Services
"LIFE SCIENCES"
IMBRIUM PHARMA
IMBRIUM PHARMA
Trademark
Word
ABANDONED
Owner:
Serial:88094469
Filed:Aug 27, 2018
Classes:5
Goods & Services
"PHARMA"
IMBRIUM THERAPEUTICS
IMBRIUM THERAPEUTICS
Trademark
Word
ABANDONED
Owner:
Serial:88094489
Filed:Aug 27, 2018
Classes:5
Goods & Services
"THERAPEUTICS"
IMBRIUM THERAPEUTICS
IMBRIUM THERAPEUTICS
Trademark
Word
REGISTERED
Owner:
Serial:88977444
Filed:Aug 27, 2018
Classes:5
Registration:6076740
Registered:Jun 9, 2020
Goods & Services
Pharmaceutical preparations for the treatment of central nervous system disorders; "THERAPEUTICS"
IMMERSIVE LIFESCIENCES
IMMERSIVE LIFESCIENCES
Trademark
Word
ABANDONED
Owner:
Serial:88094544
Filed:Aug 27, 2018
Classes:5
Goods & Services
"LIFE SCIENCES"
IMMERSIVE PHARMA
IMMERSIVE PHARMA
Trademark
Word
ABANDONED
Owner:
Serial:88094559
Filed:Aug 27, 2018
Classes:5
Goods & Services
"PHARMA"
IMMERSIVE THERAPEUTICS
IMMERSIVE THERAPEUTICS
Trademark
Word
ABANDONED
Owner:
Serial:88094565
Filed:Aug 27, 2018
Classes:5
Goods & Services
"THERAPEUTICS"
MANIFEST LIFESCIENCES
MANIFEST LIFESCIENCES
Trademark
Word
ABANDONED
Owner:
Serial:88094570
Filed:Aug 27, 2018
Classes:5
Goods & Services
"LIFE SCIENCES"
MANIFEST PHARMA
MANIFEST PHARMA
Trademark
Word
ABANDONED
Owner:
Serial:88094577
Filed:Aug 27, 2018
Classes:5
Goods & Services
"PHARMA"
MANIFEST THERAPEUTICS
MANIFEST THERAPEUTICS
Trademark
Word
ABANDONED
Owner:
Serial:88094572
Filed:Aug 27, 2018
Classes:5
Goods & Services
"THERAPEUTICS"
ADHANSIA XR
ADHANSIA XR
Service Mark
Word
ABANDONED
Owner:
Serial:87756623
Filed:Jan 16, 2018
Classes:44
Goods & Services
"XR"
ADHANSIA XR
ADHANSIA XR
Trademark
Word
REGISTERED
Owner:
Serial:87982478
Filed:Jan 16, 2018
Classes:5
Registration:5973730
Registered:Jan 28, 2020
Goods & Services
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder; "XR"
AVRIDI
AVRIDI
Trademark
Word
ABANDONED
Owner:
Serial:87638137
Filed:Oct 9, 2017
Classes:5
TARGINIQ
TARGINIQ
Trademark
Word
ABANDONED
Owner:
Serial:87637163
Filed:Oct 6, 2017
Classes:5
201
201
Service Mark
Combined
ABANDONED
Owner:
Serial:87507755
Filed:Jun 27, 2017
Classes:35
FACTORY 201
FACTORY 201
Service Mark
Combined
ABANDONED
Owner:
Serial:87507744
Filed:Jun 27, 2017
Classes:35
FACTORY 201
FACTORY 201
Service Mark
Word
ABANDONED
Owner:
Serial:87491564
Filed:Jun 16, 2017
Classes:35
TARGINIQ ER
TARGINIQ ER
Trademark
Combined
ABANDONED
Owner:
Serial:87479185
Filed:Jun 7, 2017
Classes:5
Goods & Services
"ER"
TARGINIQ ER
TARGINIQ ER
Trademark
Word
ABANDONED
Owner:
Serial:87479139
Filed:Jun 7, 2017
Classes:5
Goods & Services
"ER"
VERFENDRA
VERFENDRA
Trademark
Word
ABANDONED
Owner:
Serial:87445033
Filed:May 10, 2017
Classes:5
VERFYNDA
VERFYNDA
Trademark
Word
ABANDONED
Owner:
Serial:87445030
Filed:May 10, 2017
Classes:5
ADHANSIA
ADHANSIA
Trademark
Word
REGISTERED
Owner:
Serial:87440283
Filed:May 8, 2017
Classes:5, 44
Registration:6208234
Registered:Dec 1, 2020
Goods & Services
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis | Providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system
LAFENDRA
LAFENDRA
Trademark
Word
ABANDONED
Owner:
Serial:87030250
Filed:May 9, 2016
Classes:5
AVRIDI
AVRIDI
Trademark
Word
ABANDONED
Owner:
Serial:86496025
Filed:Jan 6, 2015
Classes:5
GAVRIEX
GAVRIEX
Trademark
Word
ABANDONED
Owner:
Serial:86496027
Filed:Jan 6, 2015
Classes:5
TROFFITA
TROFFITA
Trademark
Word
ABANDONED
Owner:
Serial:86496028
Filed:Jan 6, 2015
Classes:5
VOLTIMA
VOLTIMA
Trademark
Word
ABANDONED
Owner:
Serial:86496024
Filed:Jan 6, 2015
Classes:5
HYSINGLA ER
HYSINGLA ER
Trademark
Combined
ABANDONED
Owner:
Serial:86446650
Filed:Nov 6, 2014
Classes:5
Goods & Services
"ER"
POEM
POEM
Trademark
Word
CANCELLED
Owner:
Serial:86444304
Filed:Nov 4, 2014
Classes:16
Registration:5119946
Registered:Jan 10, 2017
PIC PRODUCT INFORMATION CENTER A SERVICE OF PURDUE PHARMA L.P.
PIC PRODUCT INFORMATION CENTER A SERVICE OF PURDUE PHARMA L.P.
Service Mark
Combined
ABANDONED
Owner:
Serial:86282145
Filed:May 15, 2014
Classes:35
Goods & Services
"PRODUCT INFORMATION CENTER", "A SERVICE OF", AND "L.P."
POEM
POEM
Service Mark
Word
ABANDONED
Owner:
Serial:86269695
Filed:May 2, 2014
Classes:41
PIC PRODUCT INFORMATION CENTER A SERVICE OF PURDUE PHARMA L.P.
PIC PRODUCT INFORMATION CENTER A SERVICE OF PURDUE PHARMA L.P.
Service Mark
Combined
ABANDONED
Owner:
Serial:86262964
Filed:Apr 25, 2014
Classes:44
Goods & Services
"PRODUCT INFORMATION CENTER"
TARGINIQ ER
TARGINIQ ER
Trademark
Combined
ABANDONED
Owner:
Serial:86262976
Filed:Apr 25, 2014
Classes:5
Goods & Services
"ER"
HYDURIM ER
HYDURIM ER
Trademark
Word
ABANDONED
Owner:
Serial:86242692
Filed:Apr 4, 2014
Classes:5
Goods & Services
"ER"
HYSINGLA ER
HYSINGLA ER
Trademark
Word
REGISTERED
Owner:
Serial:86242700
Filed:Apr 4, 2014
Classes:5
Registration:4713945
Registered:Mar 31, 2015
Goods & Services
Analgesics; "ER"
DILIGIX
DILIGIX
Trademark
Word
ABANDONED
Owner:
Serial:86235780
Filed:Mar 28, 2014
Classes:5
ENCASIX
ENCASIX
Trademark
Word
ABANDONED
Owner:
Serial:86235773
Filed:Mar 28, 2014
Classes:5
RESILIX
RESILIX
Trademark
Word
ABANDONED
Owner:
Serial:86235777
Filed:Mar 28, 2014
Classes:5
RESISTEC
RESISTEC
Trademark
Word
ABANDONED
Owner:
Serial:86233742
Filed:Mar 27, 2014
Classes:5
86091911
86091911
Service Mark
Design
ABANDONED
Owner:
Serial:86091911
Filed:Oct 15, 2013
Classes:42
PURDUE PEDIATRIC CLINICAL TRIALS
PURDUE PEDIATRIC CLINICAL TRIALS
Service Mark
Combined
ABANDONED
Owner:
Serial:86091901
Filed:Oct 15, 2013
Classes:42
Goods & Services
"PEDIATRIC CLINICAL TRIALS"
HYDROCONTIN ER
HYDROCONTIN ER
Trademark
Word
ABANDONED
Owner:
Serial:86090407
Filed:Oct 14, 2013
Classes:5
Goods & Services
"ER"
TARGINIQ ER
TARGINIQ ER
Trademark
Word
ABANDONED
Owner:
Serial:86090441
Filed:Oct 14, 2013
Classes:5
Goods & Services
"ER"
PARTNERS AGAINST PAIN
PARTNERS AGAINST PAIN
Service Mark
Combined
CANCELLED
Owner:
Serial:85957829
Filed:Jun 12, 2013
Classes:44
Registration:4432640
Registered:Nov 12, 2013
HYDROCONTIN
HYDROCONTIN
Trademark
Word
ABANDONED
Owner:
Serial:85889003
Filed:Mar 28, 2013
Classes:5
DOLIHYD
DOLIHYD
Trademark
Word
ABANDONED
Owner:
Serial:85783567
Filed:Nov 20, 2012
Classes:5
DURHYDA
DURHYDA
Trademark
Word
ABANDONED
Owner:
Serial:85783560
Filed:Nov 20, 2012
Classes:5
HYDOLA
HYDOLA
Trademark
Word
ABANDONED
Owner:
Serial:85783555
Filed:Nov 20, 2012
Classes:5
HYDOLRA
HYDOLRA
Trademark
Word
ABANDONED
Owner:
Serial:85783561
Filed:Nov 20, 2012
Classes:5
HYDURIM
HYDURIM
Trademark
Word
ABANDONED
Owner:
Serial:85783550
Filed:Nov 20, 2012
Classes:5
HYJORA
HYJORA
Trademark
Word
ABANDONED
Owner:
Serial:85783559
Filed:Nov 20, 2012
Classes:5
HYSINGLA
HYSINGLA
Trademark
Word
REGISTERED
Owner:
Serial:85783558
Filed:Nov 20, 2012
Classes:5
Registration:4708683
Registered:Mar 24, 2015
Goods & Services
Analgesics
HYTINUUM
HYTINUUM
Trademark
Word
ABANDONED
Owner:
Serial:85783564
Filed:Nov 20, 2012
Classes:5
HYTRUXA
HYTRUXA
Trademark
Word
ABANDONED
Owner:
Serial:85783556
Filed:Nov 20, 2012
Classes:5
HYTRUZA
HYTRUZA
Trademark
Word
ABANDONED
Owner:
Serial:85783557
Filed:Nov 20, 2012
Classes:5
PAFREZYN
PAFREZYN
Trademark
Word
ABANDONED
Owner:
Serial:85783566
Filed:Nov 20, 2012
Classes:5
QHYD
QHYD
Trademark
Word
ABANDONED
Owner:
Serial:85783548
Filed:Nov 20, 2012
Classes:5
RULINQUA
RULINQUA
Trademark
Word
ABANDONED
Owner:
Serial:85783551
Filed:Nov 20, 2012
Classes:5
TRUHYGA
TRUHYGA
Trademark
Word
ABANDONED
Owner:
Serial:85783563
Filed:Nov 20, 2012
Classes:5
VYLIBEC
VYLIBEC
Trademark
Word
ABANDONED
Owner:
Serial:85783554
Filed:Nov 20, 2012
Classes:5
VYTRUXA
VYTRUXA
Trademark
Word
ABANDONED
Owner:
Serial:85783549
Filed:Nov 20, 2012
Classes:5
PARTNERS AGAINST PAIN
PARTNERS AGAINST PAIN
Service Mark
Word
CANCELLED
Owner:
Serial:85530903
Filed:Feb 1, 2012
Classes:44
Registration:4202448
Registered:Sep 4, 2012
PARTNERS AGAINST PAIN
PARTNERS AGAINST PAIN
Service Mark
Combined
CANCELLED
Owner:
Serial:85530966
Filed:Feb 1, 2012
Classes:44
Registration:4202450
Registered:Sep 4, 2012

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.

View our privacy policy